81 Biggest Movers From Yesterday
Gainers
Evaxion Biotech A/S (NASDAQ: EVAX) shares jumped 95.1% to close at $12.68 on Thursday after dropping over 10% on Wednesday.
55 Stocks Moving In Thursday’s Mid-Day Session
Gainers
Evaxion Biotech A/S (NASDAQ: EVAX) shares climbed 179% to $18.17 after dropping over 10% on Wednesday.
Morgan Stanley Maintains Equal-Weight on Syndax Pharmaceuticals, Raises Price Target to $21
Morgan Stanley analyst David Lebowitz maintains Syndax Pharmaceuticals (NASDAQ:SNDX) with a Equal-Weight and raises the price target from $20 to $21.
The Daily Biotech Pulse: Eisai, Biogen Pursue Approval Of Second Alzheimer’s Treatment; Sanofi Changes mRNA Strategy; GSK Subsidiary To Develop Long-Acting HIV Preventive
Here's a roundup of top developments in the biotech space over the last 24 hours:
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs Sept. 27)
Syndax Pharma, Incyte Ink Licensing Pact For Graft Vs. Host Disease Candidate
Syndax Pharmaceuticals Inc (NASDAQ:SNDX) and Incyte Corporation (NASDAQ:INCY) have entered into an exclusive worldwide collaboration and license agreement to develop and commercialize Syndax’s…
Syndax Pharmaceuticals’s Return On Capital Employed Insights
According to data from Benzinga Pro, during Q2, Syndax Pharmaceuticals's (NASDAQ:SNDX) reported sales totaled $379.00 thousand. Despite a 17.78% increase in earnings, the company posted a loss of $22.33 million.
